申请人:BANYU PHARMACEUTICAL CO., LTD.
公开号:EP1914232A1
公开(公告)日:2008-04-23
The invention provides the compounds represented by the formula (I)
in which, R stands for a dihydroxy-substituted C1- C6 alkyl group, and Cy stands for an optionally substituted C6 - C10 bi- or tri-cyclic aliphatic carbocyclic group. These compounds act as nociceptin receptor antagonist, and are useful, for example, as relievers against tolerance to narcotic analgesic, dependence on narcotic analgesic or addiction; analgesic enhancers; antiobestic or appetite suppressors; treating or prophylactic agents for cognitive impairment and dementia/amnesia; agents for treating developmental cognitive abnormality; remedy for schizophrenia; agents for treating neurodegenerative diseases; anti-depressant or treating agents for affective disorder; treating or prophylactic agents for diabetes insipidus; treating or prophylactic agents for polyuria; and remedy for hypotension and the like.
本发明提供了式 (I) 所代表的化合物
其中,R 代表二羟基取代的 C1- C6 烷基,Cy 代表任选取代的 C6 - C10 双环或三环脂族碳环基团。这些化合物具有痛觉素受体拮抗剂的作用,例如,可用于缓解对麻醉性镇痛剂的耐受性、对麻醉性镇痛剂的依赖性或成瘾性;镇痛增强剂;抗镇静剂或食欲抑制剂;认知障碍和痴呆/失智症的治疗或预防剂;治疗认知发育异常的药物;治疗精神分裂症的药物;治疗神经退行性疾病的药物;抗抑郁剂或治疗情感障碍的药物;治疗或预防糖尿病的药物;治疗或预防多尿症的药物;以及治疗低血压的药物等。